Press release from aTyr
Reprinted with permission
Contact: Mark Johnson Sr. Director, Investor Relations firstname.lastname@example.org +1-858-223-1163
aTyr Pharma Reports Promising Signals of Clinical … http://fshfriends.org/blog/atyr-pharma-reports-promising-signals-resolaris/
Webcast to be held Oct 28, 2016 at 10:00 a.m. EDT with Dr. Statland. Archive available on website.
An archive of the webcast can be accessed on the Company's website.
Acceleron Pharma Inc. will host an educational webinar on FSHD and the Company's Phase 2 clinical trial of A… http://fshfriends.org/blog/acceleron-webcast-overview-ace-083-phase-2-trial/
Tel: EIN 86-1108537